Recruiting Nephrotic Syndrome Studies in Birmingham
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor that, when administered concurrently with an ARB, is designed to inhibit recruitment of monocytes implicated in the inflamma...
Belimumab With Rituximab for Primary Membranous Nephropathy
The primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituxim...
About Nephrotic Syndrome Clinical Trials in Birmingham
Nephrotic syndrome is a kidney disorder characterized by heavy proteinuria, low blood albumin, high cholesterol, and swelling. It can be caused by various underlying conditions. Treatment targets the underlying cause and may include immunosuppressive medications and supportive care.
There are currently 2 nephrotic syndrome clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 344 participants. Research is being sponsored by Dimerix Bioscience Pty Ltd, National Institute of Allergy and Infectious Diseases (NIAID). Clinical trial participation is free and participants receive study-related medical care at no cost.
Nephrotic Syndrome Clinical Trials in Birmingham — FAQ
Are there nephrotic syndrome clinical trials in Birmingham?
Yes, there are 2 nephrotic syndrome clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What nephrotic syndrome treatments are being tested?
The 2 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for nephrotic syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov